Keyphrases
Patients with COVID-19
83%
Low-dose Hydrocortisone
83%
Severe Hypoxia
83%
Randomized Placebo-controlled Trial
83%
Coronavirus Disease (COVID)
83%
COVID-19
62%
Hydrocortisone
62%
Corticosteroids
41%
Placebo
41%
Number of Days
41%
Days Alive without Life Support
41%
Placebo-controlled
20%
External Evidence
20%
Hospital Discharge
20%
Placebo Groups
20%
Serious Adverse Reaction
20%
Clinical Database
20%
Clinical Trials
20%
Severe COVID-19
20%
Drug Regulation
20%
Adjusted Means
20%
European Union
20%
Supplemental Oxygen
20%
Patient-centered Outcomes
20%
Mechanical Ventilation
20%
Critically Ill Patients
20%
General Medical Care
8%
Medicine and Dentistry
Adverse Event
97%
COVID-19
91%
Low Drug Dose
83%
Hydrocortisone
83%
Placebo
83%
Hypoxia
83%
Intensive Care Medicine
83%
Randomized Clinical Trial
83%
Clinical Trial
27%
Intensive Care Unit
25%
Artificial Respiration
13%
Intensive Care
8%
Secondary Research
8%
Medical Care
8%
Drug Screening
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Hydrocortisone
83%
Placebo
83%
Hypoxia
83%
Randomized Clinical Trial
83%
Clinical Trial
33%
Drug Screening
8%
